CVS Health Corporation provides health services in the United States. The company's Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail order, mail order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. Its Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to chronic care facilities and other care settings. As of December 31, 2020, it operated approximately 9,900 retail locations and 1,100 MinuteClinic locations, as well as online retail pharmacy websites, LTC pharmacies, and onsite pharmacies. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.
IPO Year:
Exchange: NYSE
Website: cvshealth.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/18/2024 | $60.00 → $66.00 | Equal Weight → Overweight | Wells Fargo |
| 10/10/2024 | $63.00 → $82.00 | Equal Weight → Overweight | Barclays |
| 10/4/2024 | $59.00 → $85.00 | Hold → Buy | TD Cowen |
| 5/30/2024 | $61.00 | Neutral | Robert W. Baird |
| 5/7/2024 | $99.00 → $59.00 | Buy → Hold | TD Cowen |
| 5/2/2024 | $85.00 → $60.00 | Buy → Neutral | UBS |
| 5/1/2024 | Overweight → Neutral | Cantor Fitzgerald | |
| 5/1/2024 | $87.00 → $60.00 | Outperform → Market Perform | Leerink Partners |
| 3/6/2024 | $78.00 | Equal Weight | Barclays |
| 2/26/2024 | $88.00 | Outperform | Leerink Partners |
8-K - CVS HEALTH Corp (0000064803) (Filer)
13F-HR - CVS HEALTH Corp (0000064803) (Filer)
8-K - CVS HEALTH Corp (0000064803) (Filer)
10-Q - CVS HEALTH Corp (0000064803) (Filer)
8-K - CVS HEALTH Corp (0000064803) (Filer)
8-K - CVS HEALTH Corp (0000064803) (Filer)
13F-HR - CVS HEALTH Corp (0000064803) (Filer)
10-Q - CVS HEALTH Corp (0000064803) (Filer)
8-K - CVS HEALTH Corp (0000064803) (Filer)
11-K - CVS HEALTH Corp (0000064803) (Filer)
Wells Fargo upgraded CVS Health from Equal Weight to Overweight and set a new price target of $66.00 from $60.00 previously
Barclays upgraded CVS Health from Equal Weight to Overweight and set a new price target of $82.00 from $63.00 previously
TD Cowen upgraded CVS Health from Hold to Buy and set a new price target of $85.00 from $59.00 previously
Robert W. Baird initiated coverage of CVS Health with a rating of Neutral and set a new price target of $61.00
TD Cowen downgraded CVS Health from Buy to Hold and set a new price target of $59.00 from $99.00 previously
UBS downgraded CVS Health from Buy to Neutral and set a new price target of $60.00 from $85.00 previously
Cantor Fitzgerald downgraded CVS Health from Overweight to Neutral
Leerink Partners downgraded CVS Health from Outperform to Market Perform and set a new price target of $60.00 from $87.00 previously
Barclays initiated coverage of CVS Health with a rating of Equal Weight and set a new price target of $78.00
Leerink Partners initiated coverage of CVS Health with a rating of Outperform and set a new price target of $88.00
3 - CVS HEALTH Corp (0000064803) (Issuer)
3 - CVS HEALTH Corp (0000064803) (Issuer)
4 - CVS HEALTH Corp (0000064803) (Issuer)
4 - CVS HEALTH Corp (0000064803) (Issuer)
4 - CVS HEALTH Corp (0000064803) (Issuer)
4 - CVS HEALTH Corp (0000064803) (Issuer)
4 - CVS HEALTH Corp (0000064803) (Issuer)
4 - CVS HEALTH Corp (0000064803) (Issuer)
4 - CVS HEALTH Corp (0000064803) (Issuer)
4 - CVS HEALTH Corp (0000064803) (Issuer)
WOONSOCKET, R.I., Nov. 19, 2024 /PRNewswire/ -- CVS Health® (NYSE: CVS) today announced that Dr. Sreekanth Chaguturu will be President, Health Care Delivery, in addition to his current role as Executive Vice President and Chief Medical Officer of CVS Health. Dr. Chaguturu replaces Mike Pykosz, who has decided to leave the company. "Sree and I worked closely together when he started at CVS Health, serving as chief medical officer of CVS Caremark. In that role, and as the leader of Medical Affairs at our company, Sree has served as a trusted advisor to our clients, their members
CVS Health Board of Directors appoints four new members: Leslie Norwalk, Larry Robbins, Guy Sansone, and Doug Shulman Appointments follow productive engagement with Glenview Capital Management WOONSOCKET, R.I., Nov. 18, 2024 /PRNewswire/ -- The Board of Directors of CVS Health (NYSE:CVS) today announced the appointment of four new board members: Leslie Norwalk, Larry Robbins, Guy Sansone, and Doug Shulman, following productive discussions with Glenview Capital Management. "In our discussions with the leadership at Glenview, we agreed that we can deliver greater value from our
WOONSOCKET, R.I., Nov. 11, 2024 /PRNewswire/ -- CVS Health® (NYSE: CVS) today announced that Chief Financial Officer Tom Cowhey will participate in a fireside chat with investors at the Wolfe 2024 Healthcare Conference on November 19, 2024, at approximately 10:20 am ET. An audio webcast of the event will be broadcast simultaneously on the Investor Relations portion of the CVS Health website at investors.cvshealth.com where it will be archived for a period of one year. About CVS HealthCVS Health® is the leading health solutions company, delivering care like no one else can. We reach more people and improve the health of communities across America through our local presence, digital channels a
Financial Highlights Third quarter total revenues increased to $95.4 billion, up 6.3% compared to the prior yearThird quarter GAAP diluted EPS of $0.07 and Adjusted EPS of $1.09Third quarter GAAP diluted EPS and Adjusted EPS include charges to record premium deficiency reserves of approximately $1.1 billion ($0.63 per share) in the Health Care Benefits segmentGenerated year-to-date cash flow from operations of $7.2 billionCEO Commentary "Our integrated model accelerates our ability to uniquely do what is most important to today's health care consumers: deliver lower cost of care, a simpler experience and better outcomes. Our third quarter results reflect strong performance in the Health Serv
Prem Shah named Group President, CVS Health; Steve Nelson named President, Aetna WOONSOCKET, R.I., Nov. 6, 2024 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced Prem Shah will be Group President, and will continue to report to David Joyner, President and Chief Executive Officer. In addition, the company announced the appointment of Steve Nelson as President, Aetna, and he will also report to Joyner. Both appointments are effective today. As Group President, Shah will be responsible for the operational performance and integrated value creation across CVS Caremark, CVS Pha
Roger Farah Named Executive Chairman of the Board Company provides preliminary guidance for third quarter 2024 GAAP diluted Earnings per Share (EPS) of $0.03 to $0.08 and Adjusted EPS of $1.05 to $1.10 WOONSOCKET, R.I., Oct. 18, 2024 /PRNewswire/ -- CVS Health (NYSE:CVS) today announced that David Joyner was appointed President and Chief Executive Officer, effective October 17, replacing Karen Lynch, who stepped down from her position in agreement with the company's Board of Directors. Joyner also joined the Board of Directors. In addition, current Chairman of the Board, Roger Farah, will now be Executive Chairman.
This offering for self-insured customers is designed to further reduce health care costs, improve health outcomes and simplify the health care experience HARTFORD, Conn., Oct. 16, 2024 /PRNewswire/ -- Aetna, a CVS Health company (NYSE:CVS), now offers SimplePay Health, an alternative health plan designed to further meet the diverse needs of our clients and members. This plan, for self-insured clients, works to further reduce costs, improve health outcomes and simplify the health care experience through a differentiated approach to health care coverage. With an innovative payme
CVS Health/Morning Consult survey reveals most pharmacy teams and consumers say more care and services can and should be provided in community pharmacy Demand for pharmacy care is high, with 76% of consumers having at least one prescription for themselves or a person they care for Most consumers (81%) say they trust their local pharmacist and 83% say their pharmacist's recommendations are important to them WOONSOCKET, R.I., Oct. 15, 2024 /PRNewswire/ -- CVS Health® (NYSE:CVS) today released the Rx Report: Transforming Community Pharmacy to Make Healthier Happen Together, which explores the ongoing evolution of community pharmacy as well as opportunities for the industry to keep pace with c
Aetna to support more Michigan residents eligible for both Medicare and Medicaid DETROIT, Oct. 11, 2024 /PRNewswire/ -- Aetna®, a CVS Health® company (NYSE:CVS), announced the State of Michigan has recommended the company for a new contract to serve MI Coordinated Health beneficiaries who are eligible for both Medicare and Medicaid. Aetna was selected as part of a competitive bidding process. Under the new contract, eligible Michigan residents will have access to an Aetna Highly Integrated Dual Eligible Special Needs Plan (HIDE SNP), which provides all Medicare benefits, most
Exceptional service results in highest-ever Aetna member experience score WOONSOCKET, R.I., Oct. 10, 2024 /PRNewswire/ -- Aetna®, a CVS Health® company (NYSE:CVS), announced today that 88 percent of its Medicare Advantage (MA) members are in 2025 Medicare Advantage Prescription Drug (MAPD) plans that are rated 4 stars or higher (out of 5 stars) by the Centers for Medicare & Medicaid Services (CMS). Additionally, more than two out of three (68 percent) Aetna Medicare Advantage members are in a 4.5-star plan for 2025. "Our excellence in 2025 Star Ratings reflects our efforts to
4 - CVS HEALTH Corp (0000064803) (Issuer)
4 - CVS HEALTH Corp (0000064803) (Issuer)
4 - CVS HEALTH Corp (0000064803) (Issuer)
Financial giants have made a conspicuous bullish move on CVS Health. Our analysis of options history for CVS Health (NYSE:CVS) revealed 10 unusual trades. Delving into the details, we found 50% of traders were bullish, while 40% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $374,736, and 7 were calls, valued at $388,184. Expected Price Movements Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $53.0 to $77.5 for CVS Health over the last 3 months. Analyzing Volume & Open Interest Assessing the volume and open interest is a strategic step in options trading. These metr
Across the recent three months, 15 analysts have shared their insights on CVS Health (NYSE:CVS), expressing a variety of opinions spanning from bullish to bearish. In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 5 1 9 0 0 Last 30D 0 0 1 0 0 1M Ago 0 0 0 0 0 2M Ago 0 1 2 0 0 3M Ago 5 0 6 0 0 Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $66.13, along with a high estimate of $86.00 and a low estimate of $58.00. Observing
Cantor Fitzgerald analyst Sarah James reiterates CVS Health (NYSE:CVS) with a Neutral and maintains $58 price target.
Financial giants have made a conspicuous bullish move on CVS Health. Our analysis of options history for CVS Health (NYSE:CVS) revealed 10 unusual trades. Delving into the details, we found 50% of traders were bullish, while 50% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $303,820, and 7 were calls, valued at $615,689. What's The Price Target? Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $50.0 to $70.0 for CVS Health during the past quarter. Volume & Open Interest Trends Assessing the volume and open interest is a strategic step in options trading. These metrics she
During times of turbulence and uncertainty in the markets, even when markets are at all-time highs, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout. Benzinga readers can review the latest analyst takes on their favorite stocks by visiting our Analyst Stock Ratings page. Traders can sort through Benzinga's extensive database of analyst ratings, including by analyst accuracy. Below are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector. Pfizer Inc. (NYSE:PFE) Dividend Yield: 5.81% Cantor Fitzgerald analyst Louise Chen rei
Deep-pocketed investors have adopted a bearish approach towards CVS Health (NYSE:CVS), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in CVS usually suggests something big is about to happen. We gleaned this information from our observations today when Benzinga's options scanner highlighted 12 extraordinary options activities for CVS Health. This level of activity is out of the ordinary. The general mood among these heavyweight investors is divided, with 41% leaning bullish and 50% bearish. Among these notable options, 4 ar
The U.S. Federal Trade Commission (FTC) recently highlighted the significant influence of pharmacy benefit managers (PBMs) on drug prices due to market consolidation. This trend raises critical questions about the future of the cannabis industry, especially if cannabis is federally legalized. The Role Of PBMs And Market Influence PBMs, such as UnitedHealth Group (NYSE:UNH)'s Optum, CVS Health (NYSE:CVS)'s CVS Caremark and Cigna (NYSE:CI)'s Express Scripts, negotiate discounts, create medication lists covered by insurance and reimburse pharmacies. The FTC's interim report revealed that these three PBMs manage 79% of U.S. prescription drug claims, consolidating their power and impacting dru
The Federal Trade Commission is preparing to sue the largest three pharmacy-benefit managers over their tactics for negotiating prices for drugs including insulin, after a two-year investigation into whether the companies steer patients away from less-expensive medicines.https://www.wsj.com/health/pharma/ftc-to-sue-drug-managers-over-insulin-prices-b46af71f?mod=latest_headlines
CVS Health Board of Directors appoints four new members: Leslie Norwalk, Larry Robbins, Guy Sansone, and Doug Shulman Appointments follow productive engagement with Glenview Capital Management WOONSOCKET, R.I., Nov. 18, 2024 /PRNewswire/ -- The Board of Directors of CVS Health (NYSE:CVS) today announced the appointment of four new board members: Leslie Norwalk, Larry Robbins, Guy Sansone, and Doug Shulman, following productive discussions with Glenview Capital Management. "In our discussions with the leadership at Glenview, we agreed that we can deliver greater value from our
Prem Shah named Group President, CVS Health; Steve Nelson named President, Aetna WOONSOCKET, R.I., Nov. 6, 2024 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced Prem Shah will be Group President, and will continue to report to David Joyner, President and Chief Executive Officer. In addition, the company announced the appointment of Steve Nelson as President, Aetna, and he will also report to Joyner. Both appointments are effective today. As Group President, Shah will be responsible for the operational performance and integrated value creation across CVS Caremark, CVS Pha
Roger Farah Named Executive Chairman of the Board Company provides preliminary guidance for third quarter 2024 GAAP diluted Earnings per Share (EPS) of $0.03 to $0.08 and Adjusted EPS of $1.05 to $1.10 WOONSOCKET, R.I., Oct. 18, 2024 /PRNewswire/ -- CVS Health (NYSE:CVS) today announced that David Joyner was appointed President and Chief Executive Officer, effective October 17, replacing Karen Lynch, who stepped down from her position in agreement with the company's Board of Directors. Joyner also joined the Board of Directors. In addition, current Chairman of the Board, Roger Farah, will now be Executive Chairman.
WOONSOCKET, R.I., Aug. 14, 2024 /PRNewswire/ -- CVS Health® (NYSE: CVS) today announced that Heidi Capozzi will join the company as Executive Vice President, Chief People Officer, effective September 9. She will lead the human resources, labor relations, compensation and benefits, and corporate social responsibility teams who support CVS Health's strategy to build a world of health around every consumer. "Heidi brings a depth of experience and a breadth of industry insights to CVS Health, in particular a proven track record of hiring, building, and growing strong teams and adv
ExtraCare® is now one easy savings membership with two tiers WOONSOCKET, R.I., Jan. 4, 2024 /PRNewswire/ -- CVS Pharmacy®, the retail division of CVS Health® (NYSE:CVS), today announced the evolution of its loyalty program to include two membership tiers: ExtraCare® and ExtraCare Plus™. ExtraCare: The popular, no-fee loyalty program through which members can save hundreds of dollars1 through sale prices, email, and text personalized Deals For You, 2% back in ExtraBucks Rewards® and more, is now simpler and more valuable. ExtraCare will now include benefits previously found wit
American International Group, Inc. (NYSE:AIG) today announced that Roshan Navagamuwa will be joining AIG in December and has been named EVP and Chief Information Officer, effective January 1, 2024. Mr. Navagamuwa will report to Peter Zaffino, AIG Chairman & Chief Executive Officer, and serve on AIG's Executive Leadership Team. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231114592675/en/Roshan Navagamuwa (Photo: Business Wire) As Chief Information Officer, Mr. Navagamuwa will be responsible for AIG's global technology and cybersecurity strategy, managing core infrastructure, technology partnerships and process engineering effo
WOONSOCKET, R.I., Sept. 21, 2023 /PRNewswire/ -- CVS Health Corporation (NYSE:CVS) has appointed Michael F. Mahoney, Chairman and CEO of Boston Scientific Corporation (NYSE:BSX), a global medical technology leader, to serve on the Board of Directors (the "Board") of CVS Health, effective November 1. "Mike's focus throughout his career – to drive improvements in health outcomes and increase access to care – align with our mission at CVS Health," said CVS Health President and CEO Karen S. Lynch. "Adding a well-respected health care leader to our Board demonstrates our continued
WOONSOCKET, R.I., July 20, 2023 /PRNewswire/ -- CVS Health® Corporation (NYSE:CVS) has appointed J. Scott Kirby, CEO of United Airlines Holdings, Inc., to serve on the Board of Directors (the "Board") of CVS Health, effective October 1. "Scott is a strategic leader adept at innovating through technology in a highly regulated, consumer driven industry," said CVS Health President and CEO Karen S. Lynch. "His insights will be a tremendous asset to our Board and will help us advance our technology-forward approach to improving consumer health." Kirby joined United Airlines as pres
Board Appointments Support the Company's Previously Announced Board Transition Plan Enhabit, Inc. (NYSE:EHAB) ("Enhabit" or the "Company"), a leading national home health and hospice provider, today announced an agreement with Cruiser Capital Advisors LLC ("Cruiser") and Harbour Point Capital Management LP ("Harbour Point" ), which collectively own approximately 4.7% of the outstanding shares of Enhabit's common stock, pursuant to which Enhabit has appointed Stuart McGuigan and Barry Schochet to its board of directors, effective immediately. With these appointments the Company's board will expand temporarily to 13 directors. As Enhabit previously disclosed in May 2022 ahead of the complet
WOONSOCKET, R.I., Oct. 6, 2022 /PRNewswire/ -- CVS Health® (NYSE:CVS) today announced it has appointed Dr. Amar Desai as President, Health Care Delivery, effective October 17. He will lead the newly formed Health Care Delivery organization, overseeing implementation of key areas of the company's health services and care delivery strategy. "This new organization will leverage the strength of the CVS Health portfolio to develop and implement payor-agnostic products and services," said CVS Health President and CEO Karen S. Lynch. "Amar's deep background in clinical delivery and v
SC 13G - CVS HEALTH Corp (0000064803) (Subject)
SC 13G/A - CVS HEALTH Corp (0000064803) (Subject)
SC 13G/A - CVS HEALTH Corp (0000064803) (Subject)
SC 13G/A - CVS HEALTH Corp (0000064803) (Subject)
SC 13G/A - CVS HEALTH Corp (0000064803) (Subject)
Financial Highlights Third quarter total revenues increased to $95.4 billion, up 6.3% compared to the prior yearThird quarter GAAP diluted EPS of $0.07 and Adjusted EPS of $1.09Third quarter GAAP diluted EPS and Adjusted EPS include charges to record premium deficiency reserves of approximately $1.1 billion ($0.63 per share) in the Health Care Benefits segmentGenerated year-to-date cash flow from operations of $7.2 billionCEO Commentary "Our integrated model accelerates our ability to uniquely do what is most important to today's health care consumers: deliver lower cost of care, a simpler experience and better outcomes. Our third quarter results reflect strong performance in the Health Serv
WOONSOCKET, R.I., Oct. 7, 2024 /PRNewswire/ -- CVS Health® (NYSE:CVS) will hold a conference call with analysts and investors on Wednesday, November 6th, 2024, at 8:00 a.m. ET to discuss third quarter 2024 financial results. An audio webcast of the event will be broadcast simultaneously on the Investor Relations portion of the CVS Health website at investors.cvshealth.com where it will be archived for a period of one year. About CVS HealthCVS Health® is the leading health solutions company, delivering care like no one else can. We reach more people and improve the health of communities across America through our local presence, digital channels and over 300,000 dedicated colleagues — includi
WOONSOCKET, R.I., Sept. 19, 2024 /PRNewswire/ -- CVS Health (NYSE:CVS) has announced that its board of directors has approved a quarterly dividend of sixty-six and one-half cents ($0.665 cents) per share on the Common Stock of the Corporation. The dividend is payable on November 1, 2024, to holders of record on October 21, 2024. About CVS HealthCVS Health® is the leading health solutions company, broadening access to care for millions of people nationwide. We improve the health of communities across America through our local presence, digital channels and with over 300,000 dedicated colleagues – including more than 40,000 physicians, pharmacists, nurses, and nurse practitioners. We support i
AM Best has revised the outlook to stable from positive for the Long-Term Issuer Credit Rating (Long-Term ICR) and affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term ICRs of "a" (Excellent) of Aetna Life Insurance Company (ALIC) (Hartford, CT) and the other members of Aetna Health & Life Group, which are operating entities of Aetna Inc. (Aetna) and wholly owned subsidiaries of CVS Health Corporation (CVS Health) (NYSE:CVS). The outlook of the FSR is stable. (Please see below for a detailed listing of the companies.) The Credit Ratings (ratings) of Aetna Health & Life Group reflect its balance sheet strength, which AM Best assesses as very strong, as well as it
Financial Highlights Second quarter total revenues increased to $91.2 billion, up 2.6% compared to the prior yearSecond quarter GAAP diluted EPS of $1.41 and Adjusted EPS of $1.83Generated year-to-date cash flow from operations of $8.0 billion2024 Full-Year Guidance Revised GAAP diluted EPS guidance to a range of $4.95 to $5.20 from at least $5.64Revised Adjusted EPS guidance to a range of $6.40 to $6.65 from at least $7.00Revised cash flow from operations guidance to approximately $9.0 billion from at least $10.5 billionCEO Commentary"We have many points of differentiation that position us to win now and into the future. Our innovation is accelerating more transparent pharmacy reimbursement
WOONSOCKET, R.I., July 8, 2024 /PRNewswire/ -- CVS Health (NYSE:CVS) has announced that its board of directors has approved a quarterly dividend of sixty-six and one-half cents ($0.665 cents) per share on the Common Stock of the Corporation. The dividend is payable on August 1, 2024, to holders of record on July 22, 2024. About CVS HealthCVS Health® is the leading health solutions company, broadening access to care for millions of people nationwide. We improve the health of communities across America through our local presence, digital channels and with over 300,000 dedicated colleagues – including more than 40,000 physicians, pharmacists, nurses, and nurse practitioners. We support individu
WOONSOCKET, R.I., July 8, 2024 /PRNewswire/ -- CVS Health (NYSE:CVS) will hold a conference call with analysts and investors on Wednesday, August 7th, 2024, at 8:00 a.m. ET to discuss second quarter 2024 financial results. An audio webcast of the event will be broadcast simultaneously on the Investor Relations portion of the CVS Health website at investors.cvshealth.com where it will be archived for a period of one year. About CVS HealthCVS Health® is the leading health solutions company, delivering care like no one else can. We reach more people and improve the health of communities across America through our local presence, digital channels and over 300,000 dedicated colleagues — including
First Quarter Highlights Total revenues increased to $88.4 billion, up 3.7% compared to prior yearGAAP diluted EPS of $0.88 and Adjusted EPS of $1.31Generated cash flow from operations of $4.9 billion2024 Full-Year Guidance Revised GAAP diluted EPS guidance to at least $5.64 from at least $7.06Revised Adjusted EPS guidance to at least $7.00 from at least $8.30Revised cash flow from operations guidance to at least $10.5 billion from at least $12.0 billionCEO Commentary"The current environment does not diminish our opportunities, enthusiasm, or the long-term earnings power of our company. We are confident we have a pathway to address our near-term Medicare Advantage challenges. We remain commi
WOONSOCKET, R.I., April 1, 2024 /PRNewswire/ -- CVS Health (NYSE:CVS) will hold a conference call with analysts and investors on Wednesday, May 1st, 2024, at 8:00 a.m. ET to discuss first quarter 2024 financial results. An audio webcast of the event will be broadcast simultaneously on the Investor Relations portion of the CVS Health website at investors.cvshealth.com where it will be archived for a period of one year. About CVS HealthCVS Health® is the leading health solutions company, delivering care like no one else can. We reach more people and improve the health of communities across America through our local presence, digital channels and over 300,000 dedicated colleagues — including mo
WOONSOCKET, R.I., March 21, 2024 /PRNewswire/ -- CVS Health (NYSE:CVS) has announced that its board of directors has approved a quarterly dividend of sixty-six and one-half cents ($0.665 cents) per share on the Common Stock of the Corporation. The dividend is payable on May 1, 2024, to holders of record on April 22, 2024. About CVS Health CVS Health® is the leading health solutions company, broadening access to care for millions of people nationwide. We improve the health of communities across America through our local presence, digital channels and with over 300,000 dedicated colleagues – including more than 40,000 physicians, pharmacists, nurses, and nurse practitioners. We support individ